Popular Articles

CII to take CEO delegation to Japan next year
The Japanese and Indian industry are keen to take the Japanese investment in India beyond automobiles and into sectors like infrastructure, manufacturing, trade and education. The view emerged at a meeting between the Indian industry and a Japanese delegation, led by Prime Minister Yukio Hatoyama. Both the countries found that much more work had to be done for a comprehensive Economic Partnership Agreement (EPA) to fructify.

Sensex up 33 pts at opening bell
The Sensex has opened at 17,378 - up 33 points. The index is now up 126 points at 17,473.

News of the day

GE to sell security unit to United Technologies
US conglomerate General Electric (GE) today announced it would sell its security unit to United Technologies Corp for $1.82 billion.
Public Company

GSK to launch 'promecta' in India by 2009-end

Glaxo SmithKline Pharmaceutical today said it is looking at launching its patented medicine promecta, used in treatment of depleted platelet count, in India by this year-end or early next year. - Aurobindo Pharma receives Swissmedic approval for cefepime for injection - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Sun Pharma invalidates Eli Lilly"s Gemzar patent - Glenmark"s drug fails clinical trials - Aurobindo Pharma to acquire Trident Life Sciences "We are looking to launch our promecta in the Indian market in the fourth quarter of this year or in the first quarter of next year," GSK Vice President South Asia and Managing Director India Hasit Joshipura told reporters on the sidelines of a function here. When asked if the company has got drug regulator DCGI nod for launching the medicine here, he said, "We have applied for the regulatory approval but we haven"t got it yet. But we hope to get it by the end of this year of early next year."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):